Client News
Mainz Biomed expands corporate health program for ColoAlert with the addition of three new companies in Germany
4th April 2023
Destiny Pharma: Landmark data published on successful NTCD-M3 gut colonisation after fidaxomicin administration
4th April 2023
Carbios licensing documentation ready for worldwide industrial and commercial deployment of its PET biorecycling technology
3rd April 2023
Destiny Pharma: notice of full year results and investor presentation
3rd April 2023
Mainz Biomed reports positive results from feasibility study evaluating its portfolio of novel mRNA biomarkers for early detection of advanced colorectal adenomas
29th March 2023
Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize GAL-101, a Phase 2/3-ready small molecule, to treat ophthalmic indications with high unmet medical need
29th March 2023
Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry
28th March 2023
ONWARD: convocation of the 2023 annual general meeting of shareholders and proposed resolutions
28th March 2023
There is no more content to load